Erratum. Mitigating Cardiovascular Risk in Type 2 Diabetes With Antidiabetes Drugs: A Review of Principal Cardiovascular Outcome Results of EMPA-REG OUTCOME, LEADER, and SUSTAIN-6 Trials. Diabetes Care 2017;40:821–831

Detalles Bibliográficos
Autor principal: Kaul, Sanjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2018
Materias:
Errata
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829961/
https://www.ncbi.nlm.nih.gov/pubmed/29311153
http://dx.doi.org/10.2337/dc18-er03a

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829961/
https://www.ncbi.nlm.nih.gov/pubmed/29311153
http://dx.doi.org/10.2337/dc18-er03a

Ejemplares similares